What policy makers need to know about COVID-19 protective immunity
“Few would disagree that science should guide the clinical therapeutic approach to an infected person. Science must also guide policy decisions.”
Feature
Is the world ready to produce a billion doses of a COVID-19 vaccine?
Imperial researchers say integrated modelling and flexible planning will be essential for
manufacturers to meet the global COVID-19 vaccine demand.
NIHR Imperial Clinical Research Facility: the London site for the Oxford COVID-1
The NIHR ICRF has begun London based screening for the Oxford COVID-19 vaccine clinical trial which was launched last week.
Feature
Lockdown advice from a GP: Stay active, keep in touch, don’t ignore vaccinations
From the start of the coronavirus outbreak, much of the focus has been the acute impact of COVID-19 on critical care capacity in hospitals.
Imperial to begin trials of Oxford COVID-19 vaccine at London centre
Imperial College London has joined an Oxford-led clinical trial as a key site to begin testing a vaccine against COVID-19.
1
Coronavirus vaccine team secures funding to move towards human trials
Imperial researchers working on a vaccine for COVID-19 have been awarded government funding to take the work forward towards human trials.
A symposium to bring together scientists against CoViD-19 and beyond
Last Friday, experts from Chinese and British universities and governmental bodies met to discuss how to tackle the current Coronavirus epidemic.
Audio
Podcast: Coronavirus vaccine, global progress report and fighting racism
In this edition: Join the race to develop a Covid-19 vaccine, check in on the Sustainable Development Goals, and discover how to argue with a racist.
Tailor-made vaccines could almost halve rates of serious bacterial disease
New research has found that rates of disease caused by a common bacterium could be substantially reduced by changing our approach to vaccination.
Imperial researchers in race to develop a coronavirus vaccine
A microbiology lab at Imperial’s St Mary’s campus is at the centre of a scientific race to develop a vaccine against a global viral outbreak.
